Symptoms of infectious diseases in immunocompromised travelers: A prospective study with matched controls

Journal of Travel Medicine

Volumn 18, Issue 5, 2011, Pages 318-326

  Baaten, Gijs G ^a,b,c   Geskus, Ronald B ^a,d   Kint, Joan A ^a   Roukens, Anna H E ^e   Sonder, Gerard J ^a,b,c   Van Den Hoek, Anneke ^a,b  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c National Coordination Centre for Traveler's Health Advice LCR   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DIARRHEA; ENTERITIS; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; MALE; SKIN INFECTION; SYMPTOM; TRAVEL;

ADULT; COMMUNICABLE DISEASES; DEVELOPING COUNTRIES; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; TRAVEL;

EID: 80052437303     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2011.00543.x     Document Type: Article

References (34)

1. United Nations World Tourism Organization. Historical perspective of world tourism: international tourist arrivals, 1950-2005. Available at:. (Accessed 2009 Jan 2).
2. Chen LH, Wilson ME., The role of the traveler in emerging infections and magnitude of travel. Med Clin North Am 2008; 92: 1409-1432.
3. Dupont HL, Steffen R., Textbook of travel medicine and health. Hamilton, UK: BC Decker Inc., 2001.
4. Ericsson CD., Travellers with pre-existing medical conditions. Int J Antimicrob Agents 2003; 21: 181-188.
5. World Health Organization. International travel and health. Geneva, Switzerland: WHO, 2008.
6. McCarthy AE, Mileno MD., Prevention and treatment of travel-related infections in compromised hosts. Curr Opin Infect Dis 2006; 19: 450-455.
7. Landelijk coördinatiecentrum reizigersadvisering. Na- tional Coordination Centre for Traveler's Health Advice. National guideline on traveler's diarrhea. Amsterdam, The Netherlands: LCR, 2007.
8. National Travel Health Network and Centre NaTHNaC. Travellers with pre-existing medical conditions. Available at:. (Accessed 2008 Dec 14).
9. Committee to Advise on Tropical Medicine and Travel (CATMAT). The immunocompromised traveller. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2007; 33 (ACS-4): 1-24.
10. Kovarik JM, Burtin P., Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases. Expert Opin Emerg Drugs 2003; 8: 47-62.
11. Tobón GJ, Youinou P, Saraux A., The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 2010; 9: A288-A292.
12. Loftus EV Jr., Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517.
13. World Health Organization. Global distribution of hepatitis A, B and C, 2001. Wkly Epidemiol Rec 2002; 77: 45.
14. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2010. Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology, 2009.
15. Landelijk coördinatiecentrum reizigersadvisering. Na- tional Coordination Centre for Traveller's Health Advice. National guideline for non-HIV-related immunosuppressive disorders. Amsterdam, The Netherlands: LCR, 2006.
16. Spiegelhalter DJ, Thomas A, Best NG., WinBUGS version 1.2 user manual. Cambridge, UK: MRC Biostatistics Unit, 1999.
17. Gilks WR, Richardson S, Spiegelhalter DJ., Markov chain Monte Carlo in practice. London, UK: Chapman & Hall, 1996.
18. Firth D., Bias reduction of maximum likelihood estimates. Biometrika 1993; 80: 27-38.
19. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. Available at:. (Accessed 2010 Sep 1).
20. Kosmidis I., Brglm: bias reduction in binary-response GLMs. Available at:. (Accessed 2010 Sep 4).
21. Listing J, Strangfeld A, Kary S, et al., Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 2005; 52: 3403-3412.
22. Woolacott NF, Khadjesari ZC, Bruce IN, et al., Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review. Clin Exp Rheumatol 2006; 24: 587-593.
23. Doran MF, Crowson CS, Pond GR, et al., Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002; 46: 2287-2293.
24. Franklin J, Lunt M, Bunn D, et al., Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis 2007; 66: 308-312.
25. Rack J, Wichmann O, Kamara B, et al., Risk and spectrum of diseases in travelers to popular tourist destinations. J Travel Med 2005; 12: 248-253.
26. Redman CA, Maclennan A, Wilson E, Walker E., Diarrhea and respiratory symptoms among travelers to Asia, Africa, and South and Central America from Scotland. J Travel Med 2006; 13: 203-211.
27. Cobelens FG, Leentvaar-Kuijpers A, Kleijnen J, Coutinho RA., Incidence and risk factors of diarrhoea in Dutch travellers: consequences for priorities in pre-travel health advice. Trop Med Int Health 1998; 3: 896-903.
28. Pitzurra R, Steffen R, Tschopp A, Mutsch M., Diarrhoea in a large prospective cohort of European travellers to resource-limited destinations. BMC Infect Dis 2010; 10: 231.
29. Van Herck K, Van Damme P, Castelli F, et al., Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey. J Travel Med 2004; 11: 3-8.
30. United States Office of Travel and Tourism Industries. United States Travel and Tourism Statistics: 2008 US Resident Outbound, June 2009. Available at:. (Accessed 2009 Jul 4).
31. Lim E, Koh WH, Loh SF, et al., Non-thyphoidal salmonellosis in patients with systemic lupus erythematosus. A study of fifty patients and a review of the literature. Lupus 2001; 10: 87-92.
32. Dhar JM, al-Khader AA, al-Sulaiman M, al-Hasani MK., Non-typhoid Salmonella in renal transplant recipients: a report of twenty cases and review of the literature. Q J Med 1991; 78: 235-250.
33. Espelage W, an der Heiden M, Stark K, Alpers K., Characteristics and risk factors for symptomatic Giardia lamblia infections in Germany. BMC Public Health 2010; 10: 41.
34. Epple HJ., Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease. Dig Dis 2009; 27: 555-559.